[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-12-P] Antibody-dependent cellular cytotoxicity of induced pluripotent stem cell-derived natural killer T cells by anti-GD2 monoclonal antibody for neuroblastoma

^○Katsuhiro Nishimura^1,2, Takahiro Aoki^1,3, Midori Kobayashi¹, Mariko Takami¹, Daisuke Katsumi^1,2, Hiroko Yoshizawa^1,2, Shugo Komatsu², Haruhiko Koseki⁴, Tomoro Hishiki², Shinichiro Motohashi¹ (1.Department of Medical Immunology, Graduate School of Medicine, Chiba University, 2.Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 3.Department of Pediatrics, Graduate School of Medicine, Chiba University, 4.Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences)

キーワード：

induced pluripotent stem cell、invariant natural killer T cell、antibody-dependent cellular cytotoxicity、anti-GD2 monoclonal antibody、neuroblastoma

閲覧にはパスワードが必要です

ログイン

または